Skip to main content
SpringerLink
Log in

Bei der Verordnung gibt es einiges zu beachten

Schweres Asthma: Antikörper als Therapieeskalation

Severe asthma: therapy escalation with antibodies

  • FB_Seminar
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur:

  1. Nationale VersorgungsLeitlinie Asthma, 4. Auflage 2020, AWMF-Registernr. nvl-0020

Download references

Author information

Authors and Affiliations

  1. Lungen- und Bronchialheilkunde, Lungenarztpraxis Tegel, Schloßstraße 5, 13507, Berlin, Germany

    Thomas Hering

Authors
  1. Thomas Hering
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Hering.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hering, T. Schweres Asthma: Antikörper als Therapieeskalation. MMW - Fortschritte der Medizin 164, 57–61 (2022). https://doi.org/10.1007/s15006-021-0590-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-021-0590-4

Keywords:

Search

Navigation